Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126492271 | 12649227 | 1 | I | 20160801 | 20160812 | 20160812 | EXP | E2B_000657051 | CA-HQ SPECIALTY-CA-2016INT000759 | INTERCHEM | 0.00 | F | Y | 0.00000 | 20160812 | MD | CA | CA |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126492271 | 12649227 | 1 | PS | METHOTREXATE SODIUM. | METHOTREXATE SODIUM | 1 | Unknown | UNK | U | 201749 | |||||||||
| 126492271 | 12649227 | 2 | SS | ENBREL | ETANERCEPT | 1 | Unknown | UNK | U | 0 | |||||||||
| 126492271 | 12649227 | 3 | SS | XELJANZ | TOFACITINIB CITRATE | 1 | Unknown | UNK | U | 0 | |||||||||
| 126492271 | 12649227 | 4 | SS | ACTEMRA | TOCILIZUMAB | 1 | Unknown | UNK | U | 0 | |||||||||
| 126492271 | 12649227 | 5 | SS | CELEBREX | CELECOXIB | 1 | Unknown | UNK | U | 0 | |||||||||
| 126492271 | 12649227 | 6 | SS | CELEBREX | CELECOXIB | 1 | U | 0 | |||||||||||
| 126492271 | 12649227 | 7 | SS | CORTISONE | CORTISONEHYDROCORTISONE | 1 | Unknown | UNK | U | 0 | |||||||||
| 126492271 | 12649227 | 8 | SS | FOLIC ACID. | FOLIC ACID | 1 | Unknown | UNK | U | 0 | |||||||||
| 126492271 | 12649227 | 9 | SS | HUMIRA | ADALIMUMAB | 1 | Subcutaneous | UNK | U | 0 | |||||||||
| 126492271 | 12649227 | 10 | SS | ORENCIA | ABATACEPT | 1 | Unknown | UNK | U | 0 | |||||||||
| 126492271 | 12649227 | 11 | SS | PREDNISONE. | PREDNISONE | 1 | Unknown | UNK | U | 0 | |||||||||
| 126492271 | 12649227 | 12 | SS | REMICADE | INFLIXIMAB | 1 | Intravenous (not otherwise specified) | UNK | U | 0 | |||||||||
| 126492271 | 12649227 | 13 | SS | RITUXAN | RITUXIMAB | 1 | Intravenous (not otherwise specified) | UNK | U | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 126492271 | 12649227 | 1 | Rheumatoid arthritis |
| 126492271 | 12649227 | 2 | Rheumatoid arthritis |
| 126492271 | 12649227 | 3 | Rheumatoid arthritis |
| 126492271 | 12649227 | 4 | Rheumatoid arthritis |
| 126492271 | 12649227 | 5 | Rheumatoid arthritis |
| 126492271 | 12649227 | 6 | Arthritis |
| 126492271 | 12649227 | 7 | Rheumatoid arthritis |
| 126492271 | 12649227 | 8 | Rheumatoid arthritis |
| 126492271 | 12649227 | 9 | Rheumatoid arthritis |
| 126492271 | 12649227 | 10 | Rheumatoid arthritis |
| 126492271 | 12649227 | 11 | Rheumatoid arthritis |
| 126492271 | 12649227 | 12 | Rheumatoid arthritis |
| 126492271 | 12649227 | 13 | Rheumatoid arthritis |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 126492271 | 12649227 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 126492271 | 12649227 | Activities of daily living impaired | |
| 126492271 | 12649227 | Drug ineffective |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |